Author

Kotsantis I

MD, MSc, PhD - Cited by 1,359 - oncology - clinical trials

Biography

Kotsantis I is working in the 51 Airforce General Hospital, Department of Medical Oncology, Athens, Greece. His international experience includes various programs contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals. He is the Editorial Board Member of many Journals and serves as a member of various associations, apart from being an author for many books.
Title
Cited by
Year
Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting
P Economopoulou, R De Bree, I Kotsantis, A PsyrriFrontiers in oncology 9, 827, 2019201
121
2019
Tumor microenvironment and immunotherapy response in head and neck cancer
P Economopoulou, I Kotsantis, A PsyrriCancers 12 (11), 37, 2020202
37
2020
Special issue about head and neck cancers: HPV positive cancers
P Economopoulou, I Kotsantis, A PsyrriInternational Journal of Molecular Sciences 21 (9), 3388, 2020202
37
2020
The role of CXCL13 and CXCL9 in early breast cancer
E Razis, KT Kalogeras, I Kotsantis, GA Koliou, K Manousou, R Wirtz, ...Clinical Breast Cancer 20 (1), e36-e53, 2020202
26
2020
Systematic review of recurrent osteosarcoma systemic therapy
I Gazouli, A Kyriazoglou, I Kotsantis, M Anastasiou, A Pantazopoulos, ...Cancers 13 (8), 1757, 2021202
25
2021
Patterns of response to immune checkpoint inhibitors in association with genomic and clinical features in patients with head and neck squamous cell carcinoma (HNSCC)
P Economopoulou, M Anastasiou, G Papaxoinis, N Spathas, A Spathis, ...Cancers 13 (2), 286, 2021202
19
2021
Prognostic significance of IGF-1 signalling pathway in patients with advanced non-small cell lung cancer
I Kotsantis, P Economopoulou, A Psyrri, E Maratou, D Pectasides, ...Anticancer Research 39 (8), 45-4190, 2019201
18
2019
HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study
HPV E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot studyP Economopoulou, G Koutsodontis, M Avgeris, A Strati, C Kroupis, ...PLoS One 14 (5), e0215984, 2019201
16
2019
Prognostic impact of indoleamine 2, 3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma
P Economopoulou, A Kladi-Skandali, A Strati, G Koytsodontis, ...ESMO open 5 (3), e000646, 2020202
15
2020
The DNA damage response network in the treatment of head and neck squamous cell carcinoma
A Psyrri, M Gkotzamanidou, G Papaxoinis, L Krikoni, P Economopoulou, ...ESMO open 6 (2), 100075, 2021202
13
2021
Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC)
P Economopoulou, G Koutsodontis, A Strati, E Kirodimos, E Giotakis, ...Oral Oncology 94, 93-100, 2019201
12
2019
Nivolumab-related lichen planus of the lip in a patient with head and neck cancer
P Economopoulou, O Nicolatou-Galitis, I Kotsantis, A PsyrriOral Oncology 104, 104623, 2020202
11
2020
Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
P Economopoulou, I Kotsantis, G Papaxoinis, N Gavrielatou, ...Oral Oncology 111, 105013, 2020202
9
2020
Atypical patterns of responses in the era of immune checkpoint inhibitors in head and neck cancer
S Doumas, PG Foukas, P Economopoulou, I Kotsantis, A PsyrriOral Oncology 100, 104477, 2020202
8
2020
De-escalating strategies in HPV-associated head and neck squamous cell carcinoma
P Economopoulou, I Kotsantis, A PsyrriViruses 13 (9), 1787, 2021202
6
2021
Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions
P Economopoulou, A Pantazopoulos, A Spathis, I Kotsantis, ...Cells 11 (1), 32, 2021202
6
2021
Blood-based testing of mutations in patients with head and neck squamous cell carcinoma (HNSCC) using highly sensitive SafeSEQ technology
F Fostira, P Oikonomopoulou, A Kladi, D Edelstein, K Stieler, D Heim, ...Annals of Oncology 30, v49, 2019201
6
2019
Breast metastasis from neuroendocrine carcinoma of the lung: a case report and review of the literature
P Economopoulou, A Chrysikopoulou, K Goula, I Papiri, A Psyrri, ...Case Reports in Oncology 13 (3), 1281-1284, 2021202
5
2021
Molecular correlates of response to preoperative olaparib alone or with cisplatin or with durvalumab in head and neck squamous cell carcinoma (HNSCC): A Hellenic Cooperative …
A Psyrri, G Papaxoinis, N Gavrielatou, M Gkotzamanidou, ...Journal of Clinical Oncology 38 (1_suppl), 66-66, 2020202
5
2020
Tyrosine kinase inhibitors in sarcoma treatment
A Kyriazoglou, LE Gkaralea, I Kotsantis, M Anastasiou, A Pantazopoulos, ...Oncology Letters 23 (6), 1-12, 2022202
4
2022

Referred From: https://scholar.google.com/citations?user=jii-iLMAAAAJ&hl=el

Cited by
Citations 1359
h-index 15
i10-index 24
Recommended Journals
Open Access Journals